Bicara Therapeutics Inc. Common Stock Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 47.5M | 33.0M | 5.8M | 24.8M | 34.3M | 19.9M | 15.9M | 15.8M |
| Operating Expenses | 60.2M | 41.1M | 40.7M | 32.0M | 41.8M | 26.6M | 20.6M | 19.8M |
| Operating Income | -60.2M | -41.1M | -40.7M | -32.0M | -41.8M | -26.6M | -20.6M | -19.8M |
| Other Income / Gains | 4.1M | 3.8M | 4.4M | 4.7M | 5.0M | 5.9M | 3.1M | 2.7M |
| Net Income | -56.2M | -37.4M | -36.3M | -27.4M | -36.8M | -21.0M | -17.5M | -17.0M |
| EPS (Diluted) | -0.93 | -0.68 | -0.67 | -0.50 | -0.68 | -0.38 | -0.32 | -0.27 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 12.7M | 8.1M | 7.7M | 7.2M | 7.5M | 6.8M | 4.8M | 3.9M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 12.7M | 8.1M | 7.7M | 7.2M | 7.5M | 6.8M | 4.8M | 3.9M |
| Other Expenses | 0 | 0 | 27.2M | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 60.2M | 41.1M | 40.7M | 32.0M | 41.8M | 26.6M | 20.6M | 19.8M |
| Interest Income | 4.1M | 3.8M | 4.4M | 4.7M | 5.0M | 5.9M | 3.1M | 2.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 44K | 11K | 56K | 19K | 19K | 15K | 15K | 13K |
| Ebitda | -56.1M | -37.3M | -36.2M | -27.3M | -36.8M | -20.8M | -17.5M | -17.0M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -56.2M | -37.3M | -36.3M | -27.3M | -36.8M | -20.8M | -17.5M | -17.0M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | -52K | 53K | 40K | 52K | 72K | 186K | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.93 | -0.68 | -0.67 | -0.50 | -0.68 | -0.38 | -0.32 | -0.27 |
| Weighted Average Shs Out | 60.7M | 55.1M | 54.6M | 54.5M | 54.5M | 54.4M | 54.4M | 54.2M |
| Weighted Average Shs Out Dil | 60.7M | 55.1M | 54.6M | 54.5M | 54.5M | 54.4M | 54.4M | 54.2M |